Latest Posts

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More

9

Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

2nd Drug Discovery Conference

Following the success of the 1st Drug Discovery conference, we are pleased to host the next edition providing a forum for scientists and students from universities, research institutes, and the pharmaceutical industry worldwide to share exciting results and build new collaborations.

The conference speakers will cover modern trends in drug discovery related to organic synthesis, medicinal chemistry, pharmacology, structural biology, and drug delivery. The lectures will include achievements in developing anti-infective, anticancer, CNS, and cardiovascular drugs.

A special invitation is extended to the students to present their research in the poster session enabling them to interact with conference visitors and speakers.

We hope that you will join us and help us make this a very successful meeting with many interesting discussions!

Speakers:

– Ph.D. Om Prakash Sharma – VP Bioinformatics, Innoplexus AG

Participants:

– Ms. Claudia M. Hausoel – Chief Marketing Officer, Innoplexus AG

Date: September 22-24, 2022

Venue: Latvian Institute of Organic Synthesis, Riga Latvia

Read more

2nd Drug Discovery Conference